Creative Planning Johnson & Johnson Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Johnson & Johnson stock. As of the latest transaction made, Creative Planning holds 988,403 shares of JNJ stock, worth $144 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

988,403

Previous 947,321 4.34%

Holding current value

$144 Million

Previous $138 Million 15.69%

% of portfolio

0.16%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$145.48 - $167.38 $5.98 Million - $6.88 Million	41,082 Added 4.34%	988,403 $160 Million
Q2 2024 Aug 15, 2024	SELL	$144.38 - $157.78 $2.21 Million - $2.42 Million	-15,324 Reduced 1.59%	947,321 $138 Million
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $1.4 Million - $1.47 Million	9,003 Added 0.94%	962,645 $152 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $12.2 Million - $13.3 Million	-83,935 Reduced 8.09%	953,642 $149 Million
Q3 2023 Nov 16, 2023	BUY	$155.75 - $174.48 $16.5 Million - $18.5 Million	106,085 Added 11.39%	1,037,577 $162 Million
Q2 2023 Jul 21, 2023	BUY	$154.35 - $166.11 $3.4 Million - $3.66 Million	22,012 Added 2.42%	931,492 $154 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $309,954 - $369,893	-2,052 Reduced 0.23%	909,480 $141 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $2.59 Million - $2.91 Million	16,171 Added 1.81%	911,532 $161 Million
Q3 2022 Nov 03, 2022	SELL	$161.33 - $179.52 $3.03 Million - $3.37 Million	-18,799 Reduced 2.06%	895,361 $146 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $16.6 Million - $18.4 Million	98,890 Added 12.13%	914,160 $162 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $29.4 Million - $33.4 Million	186,162 Added 29.59%	815,270 $144 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $2.06 Million - $2.28 Million	-13,201 Reduced 2.06%	629,108 $108 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $7.97 Million - $8.86 Million	-49,363 Reduced 7.14%	642,309 $104 Million
Q2 2021 Aug 04, 2021	BUY	$159.48 - $171.07 $15.2 Million - $16.3 Million	95,449 Added 16.01%	691,672 $114 Million
Q1 2021 Apr 30, 2021	BUY	$153.07 - $170.48 $1.92 Million - $2.14 Million	12,548 Added 2.15%	596,223 $98 Million
Q4 2020 Jan 29, 2021	BUY	$137.11 - $157.38 $6.02 Million - $6.91 Million	43,934 Added 8.14%	583,675 $91.9 Million
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $4.26 Million - $4.67 Million	30,364 Added 5.96%	539,741 $80.2 Million
Q2 2020 Jul 23, 2020	BUY	$128.81 - $155.51 $2.15 Million - $2.59 Million	16,673 Added 3.38%	509,377 $71.6 Million
Q1 2020 May 05, 2020	BUY	$111.14 - $153.99 $1.28 Million - $1.77 Million	11,493 Added 2.39%	492,704 $64.6 Million
Q4 2019 Jan 30, 2020	SELL	$127.5 - $146.44 $2.94 Million - $3.38 Million	-23,081 Reduced 4.58%	481,211 $70.2 Million
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $210,483 - $235,668	1,658 Added 0.33%	504,292 $65.2 Million
Q2 2019 Jul 26, 2019	BUY	$131.15 - $144.24 $4.15 Million - $4.57 Million	31,666 Added 6.72%	502,634 $70 Million
Q1 2019 Apr 24, 2019	SELL	$125.72 - $139.79 $1.02 Million - $1.13 Million	-8,100 Reduced 1.69%	470,968 $65.8 Million
Q4 2018 Feb 01, 2019	BUY	$122.84 - $147.84 $2.34 Million - $2.81 Million	19,020 Added 4.13%	479,068 $61.8 Million
Q3 2018 Oct 25, 2018	BUY	$121.58 - $142.88 $2.77 Million - $3.25 Million	22,775 Added 5.21%	460,048 $63.6 Million
Q2 2018 Jul 20, 2018	BUY	$119.4 - $131.76 $2.92 Million - $3.22 Million	24,444 Added 5.92%	437,273 $53.1 Million
Q1 2018 Apr 18, 2018	BUY	$125.1 - $148.14 $1.84 Million - $2.17 Million	14,681 Added 3.69%	412,829 $52.9 Million
Q4 2017 Jan 17, 2018	BUY	$131.22 - $143.62 $1.86 Million - $2.04 Million	14,195 Added 3.7%	398,148 $55.6 Million
Q3 2017 Oct 17, 2017	BUY	$129.47 - $135.38 $49.7 Million - $52 Million	383,953	383,953 $49.9 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Johnson & Johnson Transaction History